Effect of a Reduction in Uric Acid on Renal Outcomes During Losartan Treatment: A Post Hoc Analysis of the Reduction of Endpoints in Non-Insulin-Dependent Diabetes Mellitus With the Angiotensin II Antagonist Losartan Trial

Hypertension - United States
doi 10.1161/hypertensionaha.111.171488
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

The Losartan Renal Protection Study--Rationale, Study Design and Baseline Characteristics of RENAAL (Reduction of Endpoints in NIDDM With the Angiotensin II Antagonist Losartan).

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2000English

Effect of the Angiotensin II Receptor Antagonist Losartan on Uric Acid and Oxypurine Metabolism in Healthy Subjects.

Internal Medicine
Internal MedicineMedicine
2002English

Long-Term Effects of Angiotensin II Receptor Antagonist Losartan on Uric Acid Metabolism in Hyperuricemic Patients

Gout and Nucleic Acid Metabolism
2002English

Serum Uric Acid Is a Strong Predictor of Stroke in Patients With Non Insulin-Dependent Diabetes Mellitus

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
1998English

Clinical Usefulness of Losartan, an Angiotensin II Receptor Antagonist With a Uricosuric Effect, and the Influence of Aspirin on the Effect in Hypertensive Patients With Hyperuricemia

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
2003English

Microalbuminuria; “Comparison of Losartan Potassium and Lisinopril in Treatment of Patients With Type Ii Diabetes Mellitus”

THE PROFESSIONAL MEDICAL JOURNAL
2017English

Seasonal Dosage-Dependent Hypersensitivity to the Angiotensin II Receptor Blocker, Losartan. A Case Report and Review

2013English

Effect of Losartan, an Angiotensin II Type 1 Receptor Antagonist on Cardiac Autonomic Functions of Rats During Acute and Chronic Inhibition of Nitric Oxide Synthesis

Physiological Research
MedicinePhysiology
2012English

Letter Regarding Article by Devereux Et Al, "Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With Atenolol: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Trial"

Circulation
Cardiovascular MedicinePhysiologyCardiology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy